Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARUC-ASA: Remission Status in UC Patients on 5-ASA
NCT05992142Phase 4Completed
- Sponsor
- Belgian IBD Research and Development
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine in ulcerative colitis (UC), sponsored by Belgian IBD Research and Development. Started Jan 2023; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05992142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05992142.